
C.ZARAGOZA CARDIOMED
@cardiomedufv
CARLOS ZARAGOZA. HEAD OF CARDIOVASCULAR RESEARCH UNIT AT UNIVERSITY FRANCISCO DE VITORIA/UNIVERSITY HOSPITAL RAMON Y CAJAL, MADRID, SPAIN.
ID: 1174311058460356609
18-09-2019 13:16:33
217 Tweet
61 Followers
68 Following


Paciente de 28 años sin antecedentes de interés con insuficiencia respiratoria. Los jóvenes no son inmunes al #COVID19. Esto no ha acabado... SEMES SeparRespira Cesar Carballo Julio Mayol Juan Torres Macho


"Grazie" la moneda de 2€ con la que #ITA hace homenaje al personal de salud por su labor durante la pandemia de #COVID19. Alberto Ramiro Esparza Julio Mayol Dr Luis Felipe Cabrera Vargas MD FACS MACC MACCVA Dr. Ariel Vazquez G. Francisco Leyva M Eduardo Leyva M. Juan Puebla #CollezioneNumismatica2021


ℹ️ El ministro Pedro Duque presenta las novedades de las convocatorias de la Agencia Estatal de Investigación , el @CDTIoficial y el Instituto de Salud Carlos III (ISCIII) 🗓️ miércoles 7 de julio a las 11:00 h. Puedes seguir en streaming la rueda de prensa aquí ➡️ youtube.com/watch?v=PfcNYD…






NAP9: a brand new paramagnetic nanoparticle that induces cardiac protection in pigs subjected to acute myocardial infarction ahajournals.org/doi/abs/10.116… #AHAJournals C.ZARAGOZA CARDIOMED Investigación UFV Carlos Zaragoza Allison G. Hays, MD Chetan Shenoy



Circulation Research July 7th Issue is Out! ahajrnls.org/3wPOBJJ Cover: Immunofluorescence of cardiomyocytes (green) differentiated from iPSCs from a healthy individual demonstrating that most cells cardiomyocytes have well aligned sarcomeres (red); nuclei-blue.



Very proud to participate in this outstanding research led by Dr. Marta Saura, shedding light on the mechanisms that result in coronary microvascular dysfunction providing a new molecular target useful for patients with this coronary artery disease. Investigación UFV C.ZARAGOZA CARDIOMED






Excited to announce the release of our latest open-access publication Springer Nature #BiologyDirect. CAP1 as a novel marker of endothelial senescence in atherosclerosis, a prognostic marker of vascular aging C.ZARAGOZA CARDIOMED , Investigación UFV , Universidad Alcalá #IRYCIS
